-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Introduction: the formal signing of the transaction contractland the world's leading open technology platform biopharmaceutical company announced a drug-ming of Massachusetts Worcester Business Development Council (WBDC) officially signed for biological clinical samples and commercialization of pharmaceutical production base (drug-ming of plant 11, MFG11) land transaction contractThe base will be located within Worcester, Massachusetts The Reactory biomedical industrial park, construction area of about 107,000 square feet, is expected to be operational by 2022 and create about 150 jobsMassachusetts Lieutenant Governor Karin Polito (Karyn Polito) lady said: "Massachusetts biomedical industry scale steady growth, we believe that the arrival of biological medicine Ming will further enhance the strength of the local biomedical industry, promote regional economic sustainable developmentafter years of planning and co-ordination of local conditions of the park project, we finally came to this exciting moment today, successful completion of this project is co-crystal multi-party cooperation"
Worcester municipal consul Edward MAugustus, Jr., said: "the drug-ming of investment projects successfully landed consolidate pole position and leading bio-pharmaceutical industry in Worcester area, which not only marks our bio-pharmaceutical industry has a sound service system also demonstrates our unique industrial layout has a huge potential for development, "presidentWorcester Business development Board and MrCraig LBlais, CEO, said:." drug-ming of the first uS biopharmaceutical production base the Reactory settled in Worcester biomedical park, fully affirmed the important value of the life sciences park powerful ecosystem, will also be Attract more biopharmaceutical companies settled, to promote the play park industry cluster effect, "DrChen Zhishengdrug-ming of chief executive officer said:" The strong support of all sectors of sense Xiewusite city, we are honored stationed in biomedicine The Reactory industrial Park, is a positive contribution to the prosperity and development of local forcesMassachusetts has a perfect life sciences innovation ecosystem and top academic talent pool, we believe in our joint efforts, drug-ming of the better enabling global cooperation partners, accelerate the process of development of biological medicine, benefit more patients"
In addition, in March this year, the first time a biological medicine Ming donated to the Massachusetts medical surgical masks, support for front-line medical staff to fight the new crown epidemic, help alleviate local medical protective material shortage status quoa Editor: Mengmeng Related tags: U.S , a biological agent out, the production base
0 0